Geneva tests treatment for long-covid

Pixabay

The Geneva University Hospital is taking part in a trial to test a promising treatment for long-covid.

A Geneva biopharmaceutical company, GeNeuro, has developed an antibody which targets the persistence of inflammation after an infection. 

The trial will last for 6 months and is due to start early next year. Recruitment for test subjects has already begun. Researchers are hoping for around 200 volunteers.

The results should be known in the second half of next year. 

The company says long-covid is associated more with the Delta variant of covid – it seems to be less common with Omicron.

 

More from Bitesize News

  • Swiss World Cup dreams destroyed

    Switzerland’s World Cup dreams are over after a 6-1 drubbing by Portugal last night – its worst result since 1963.

  • Police hunt for pumpkin throwers

    Police in canton Aargau are hunting for mysterious pumpkin throwers.

  • Hundreds cut off in Valley

    Hundreds of people in the Calanca Valley in southern Graubünden remain cut off from the world after a rockfall blocked the main road heading to three villages on Sunday evening.

  • Not enough butter

    We won’t make enough butter next year, so the Federal Agriculture Office is allowing 3,000 tonnes to be imported next month.

  • New forest in Geneva

    A new forest is being created in Geneva. 400 trees are being planted around the development of the educational centre at CERN,

  • Postman fined for hitting same person - twice

    A postman in Lausanne has been fined for hitting the same person twice in the same day with his electric tricycle last year.